S&P ASX All Technology

3,102.60

0.47%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Canada
TSXV
Arch Biopartners Inc (ARCH)
Arch Biopartners Inc (ARCH) News

ARCH

Arch Biopartners (ARCH)

Arch Biopartners Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:TSXV:ARCH

1

Date	Time	Source	Headline	Symbol	Company
16/12/2020	05:08	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - ARCH	TSXV:ARCH	Arch Biopartners Inc
16/12/2020	05:05	PR Newswire (Canada)	IIROC Trading Resumption - ARCH	TSXV:ARCH	Arch Biopartners Inc
16/12/2020	03:37	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - ARCH	TSXV:ARCH	Arch Biopartners Inc
16/12/2020	03:35	PR Newswire (Canada)	IIROC Trading Halt - ARCH	TSXV:ARCH	Arch Biopartners Inc
06/11/2020	00:34	InvestorsHub NewsWire	Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial to Treat Complications from Covid-19	TSXV:ARCH	Arch Biopartners Inc
17/10/2020	01:30	InvestorsHub NewsWire	First Patient Dosed in Phase II Trial to Treat Complications in COVID-19	TSXV:ARCH	Arch Biopartners Inc
17/06/2020	01:05	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - ARCH	TSXV:ARCH	Arch Biopartners Inc
17/06/2020	01:02	PR Newswire (Canada)	IIROC Trading Resumption - ARCH	TSXV:ARCH	Arch Biopartners Inc
16/06/2020	22:52	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - ARCH	TSXV:ARCH	Arch Biopartners Inc
16/06/2020	22:50	PR Newswire (Canada)	IIROC Trading Halt - ARCH	TSXV:ARCH	Arch Biopartners Inc
08/06/2020	22:30	InvestorsHub NewsWire	Arch Biopartners submits IND to the FDA for COVID-19 Phase II trial to prevent organ inflammation.	TSXV:ARCH	Arch Biopartners Inc
08/05/2020	22:03	InvestorsHub NewsWire	Arch Biopartners Receives Health Canada Approval for COVID-19 Phase II Human Trial	TSXV:ARCH	Arch Biopartners Inc
24/04/2020	21:18	InvestorsHub NewsWire	Arch Biopartners Applies to Health Canada to Conduct COVID19 Phase II Human Trial to Prevent Lung and Kidney Inflammation	TSXV:ARCH	Arch Biopartners Inc
18/03/2020	02:53	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - ARCH	TSXV:ARCH	Arch Biopartners Inc
18/03/2020	02:49	PR Newswire (Canada)	IIROC Trading Resumption - ARCH	TSXV:ARCH	Arch Biopartners Inc
17/03/2020	00:45	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - ARCH	TSXV:ARCH	Arch Biopartners Inc
17/03/2020	00:42	PR Newswire (Canada)	IIROC Trading Halt - ARCH	TSXV:ARCH	Arch Biopartners Inc
26/09/2018	23:29	PR Newswire (Canada)	Arch Biopartners Announces Completion of GMP Manufacturing of Metablok Vials	TSXV:ARCH	Arch Biopartners Inc
14/08/2018	23:23	PR Newswire (Canada)	Arch Biopartners Engages Dalton Pharma Services for GMP Manufacturing of Metablok	TSXV:ARCH	Arch Biopartners Inc